Information technologyInvestors are bullish on digital healthcare | Internet Health Management
Investors poured lots of money into health information technology in 2016 and a big part of it was earmarked for deals related to digital and consumer-focused applications and services. Investors pumped $5.05 billion into digital healthcare technology applications and services transactions in 2016, an increase of 8.9% from $4.64 billion in 2015, says Mercom Capital.
Medical devices and equipmentSecond Theranos lab failed U.S. inspection | The Wall Street Journal
Theranos Inc. failed a second major U.S. regulatory inspection of its laboratory facilities, people familiar with the situation said, a setback the Silicon Valley blood-testing firm hasn't disclosed to investors or patients.
PharmaceuticalsSky-high prices for orphan drugs slam American families and insurers | Kaiser Health News
The orphan drug program overseen by the Food and Drug Administration is loaded with government incentives and has helped hundreds of thousands of patients. But the 34-year-old program has opened the door to almost unlimited price tags and created incentives among drugmakers to cash in, and to cash in repeatedly, a Kaiser Health News investigation shows.
Donald Trump's plans to cut U.S. corporate tax rates could trigger increased investment in the United States by Novartis, its chief executive told Reuters, despite the president-elect's recent harsh words on drug prices.
Two years after the United States saw a record 27,000 deaths involving prescription opioid medications and heroin, doctors and regulators are sharply restricting access to drugs like Oxycontin and Vicodin. But as the pendulum swings in the other direction, many patients who genuinely need drugs to manage their pain say they are being left behind.